NWRN.SW
Price:
$7.71
Market Cap:
$163.97M
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.[Read more]
Industry
Biotechnology
IPO Date
2006-12-12
Stock Exchange
SIX
Ticker
NWRN.SW
According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 206.05M. This represents a change of 105.37% compared to the average of 100.33M of the last 4 quarters.
The mean historical Enterprise Value of Newron Pharmaceuticals S.p.A. over the last ten years is 135.87M. The current 206.05M Enterprise Value has changed 15.07% with respect to the historical average. Over the past ten years (40 quarters), NWRN.SW's Enterprise Value was at its highest in in the June 2015 quarter at 313.75M. The Enterprise Value was at its lowest in in the January 2009 quarter at 0.
Average
135.87M
Median
110.00M
Minimum
45.92M
Maximum
287.23M
Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 127.97%
Maximum Annual Enterprise Value = 287.23M
Minimum Annual Increase = -51.00%
Minimum Annual Enterprise Value = 45.92M
Year | Enterprise Value | Change |
---|---|---|
2023 | 137.18M | 127.97% |
2022 | 60.17M | 31.05% |
2021 | 45.92M | -5.54% |
2020 | 48.61M | -51.00% |
2019 | 99.20M | 46.34% |
2018 | 67.79M | -43.88% |
2017 | 120.79M | -48.23% |
2016 | 233.34M | -18.76% |
2015 | 287.23M | 11.13% |
2014 | 258.47M | 83.95% |
The current Enterprise Value of Newron Pharmaceuticals S.p.A. (NWRN.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
81.09M
5-year avg
78.21M
10-year avg
135.87M
Newron Pharmaceuticals S.p.A.’s Enterprise Value is greater than Santhera Pharmaceuticals Holding AG (108.00M), less than Basilea Pharmaceutica AG (598.13M), greater than Addex Therapeutics Ltd (11.39M), greater than Evolva Holding SA (725.52K), less than Cosmo Pharmaceuticals N.V. (1.27B),
Company | Enterprise Value | Market cap |
---|---|---|
108.00M | $113.31M | |
598.13M | $555.15M | |
11.39M | $12.98M | |
725.52K | $6.56M | |
1.27B | $1.26B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Newron Pharmaceuticals S.p.A.'s Enterprise Value?
What is the highest Enterprise Value for Newron Pharmaceuticals S.p.A. (NWRN.SW)?
What is the 3-year average Enterprise Value for Newron Pharmaceuticals S.p.A. (NWRN.SW)?
What is the 5-year average Enterprise Value for Newron Pharmaceuticals S.p.A. (NWRN.SW)?
How does the current Enterprise Value for Newron Pharmaceuticals S.p.A. (NWRN.SW) compare to its historical average?